Itonis Pharmaceuticals Provides Updates on Emesyl Manufacturing
and Case Study
LAGUNA HILLS, CA -- March 11, 2016 -- InvestorsHub NewsWire
-- Itonis, Inc. (OTC
Pinksheets: ITNS) is pleased to provide this update regarding
its manufacturing of its Emesyl homeopathic nausea relief product
and regarding a case study on Emesyl.
The Company previously announced that it had narrowed its
selection of a new manufacturer to replace Oasis Health Products
for the production of Emesyl. After a considerable process of
comparing and assessing manufacturing capabilities and scheduling
deliverables in alignment with the Companys goals, there will soon
be an announcement identifying the new manufacturer along with
details of the first production order.
The Company had also commissioned a case study of Emesyl. That
case study has recently been completed, and the results are being
compiled for presentation and delivery to the Company for a
subsequent announcement and publication.
Meanwhile, Emesyl is available for purchase at www.Emesyl.com.
While it has been a time-consuming process, we are delighted
that we can move forward with a new manufacturer and eventually
renew our efforts to market and sell Emesyl, says Mark Cheung, the
Companys CEO. Concurrently we had also commissioned the case study,
now and it looks like we are achieving both the manufacturing
re-start and the case study completion at the same time.
As the inventor of Emesyl, I am especially pleased at the
company's recent progress towards renewing the production of the
product, said Dr. Charles Hensley. He added, I look forward
to participating in the growth and development of this amazing
product as it moves towards becoming a staple in every American
household.
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by
Charles Hensley, Ph.D., and its mission is to create and market
over-the-counter and prescription homeopathic products that better
people's lives. Dr. Hensley is a pioneer in the development and
marketing of safe and effective therapeutic nutraceutical and
homeopathic preparations. He was a founder of the company that
launched the Zicam Cold Remedy, making the product a household name
and forever changing the marketing and product placement paradigm
for homeopathic drugs in the United States. Dr. Hensley and his
team plan to use the same methodologies to revolutionize the
treatment of several other common ailments and other chronic
diseases.
About Itonis, Inc.
Itonis, Inc. was incorporated in the state of Nevada on July 5,
2005 under the name of Kenshou, Inc., which later changed to
Itonis, Inc. on December 2, 2005. Please visit www.itonisholdings.com.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact:
Itonis, Inc.
Office@itonisholdings.com
